Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-19

Clinical Trial Update: Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC [Phase 2]

View source ↗

Summary

A Phase II study evaluating concurrent radiotherapy with envafolimab and capecitabine in locally advanced pancreatic cancer is in progress, with status currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Envafolimab (envafolimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Pancreatic Cancer, Radiotherapy | Phase 2 | Status: UNKNOWN